Okedi is a medicine used to treat schizophrenia in adults. It contains the active substance risperidone and is intended for use in patients in whom medicines containing risperidone have been effective and have not produced unacceptable side effects when given by mouth. Okedi is a type of medicine called a ‘hybrid medicine’. This means that it is similar to a reference medicine containing the same active substance, but it is presented in a different way. While the reference medicine for Okedi, Risperdal tablets, is taken daily by mouth, Okedi is provided as a monthly injection.
Therapeutic Indication
### Therapeutic indication Treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
Therapeutic Area (MeSH)
ATC Code
N05AX08
ATC Item
risperidone
Pharmacotherapeutic Group
Psycholeptics
Active Substance (Summary)
INN / Common Names
EMA Name
Okedi
Medicine Name
Okedi
Aliases
N/ANo risk management plan link.
